Skip to main content

Table 1 Baseline characteristics of the study participants by treatment arm at the Dafra health district medical centre, Burkina Faso, 2008–2010

From: In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso

Intention to treat population mean ± standard deviation ASAQ N = 220 AL N = 220 Total N = 440
Gender m/f, % 45.4/54.6 55.6/44.6 50.5/49.6
Age, year 6.4 ± 3.2 6.4 ± 3.1 6.5 ± 3.1
Height, cm 114.3 ± 19.4 114 ± 19.5 114.15 ± 19.4
Weight, kg 19.1 ± 7.5 18.9 ± 8.0 19.01 ± 7.7
GMPD, parasitaemia/µl 44567 47074 45803
  1. AL artemether–lumefantrine, ASAQ artesunate plus amodiaquine, GMPD geometric mean of parasite density